𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders

✍ Scribed by Abouch Valenty Krymchantowski; Carla da Cunha Jevoux; Marcelo E. Bigal

Publisher
Springer
Year
2011
Tongue
English
Weight
279 KB
Volume
13
Category
Article
ISSN
1129-2369

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Macrogol for the treatment of constipati
Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study
✍ Roberta Zangaglia; Emilia Martignoni; Margaret Glorioso; Maria Ossola; Giulio Ri πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 2 views

## Abstract Chronic constipation is the most frequent symptom of autonomic system involvement in Parkinson's disease (PD). Quite often the symptom is severe and impairs patients' quality of life. The objective of this study is to determine the efficacy and safety of an isosmotic macrogol solution f

Randomized controlled trial of desmopres
Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: A multicenter, double-blind study
✍ Dr. Roberto de Franchis; Paolo G. Arcidiacono; Luca Carpinelli; Bruno Andreoni; πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 702 KB

l-Deamino-8-D-arginine vasopressin (DDAVP, desmopressin), a synthetic analog of the antidiuretic hormone L-arginine vasopressin, improves hemostasis parameters in cirrhotic patients. Hence its use in combination with a vasoactive drug such as terlipressin might improve the performance of this drug i

Combined hormonal therapy with high-dose
Combined hormonal therapy with high-dose diethylstilbestrol diphosphate (DES-DP) intravenous infusion plus vindesine (VND) for the treatment of advanced prostatic carcinoma: A controlled study
✍ Juan C. Cervellino; Carlos E. Araujo; Claudia Pirisi; Oscar Podskubka; Eduardo M πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 335 KB

Fifty-one patients with stage D prostate cancer, who had failed primary hormone treatment, were treated with diethylstilbestrol diphosphate (DES-DP) 1.5 g 24 hr intravenous infusion from day 1 to day 7 (group A). In group B, patients were treated with DES-DP as in A, plus vindesine (VND) 3 mg/m2 int